Literature DB >> 3124760

Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase.

R K Kutty1, R F Daniel, D E Ryan, W Levin, M D Maines.   

Abstract

In this report we provide data, for the first time, demonstrating the conversion of the heme moiety of certain cytochrome P-450 and P-420 preparations, to biliverdin, catalyzed by heme oxygenase. We have used purified preparations of cytochromes P-450c, P-450b, P-450/P-420c, or P-450/P-420b as substrates in a heme oxygenase assay system reconstituted with heme oxygenase isoforms, HO-2 or HO-1, NADPH-cytochrome c (P-450) reductase, biliverdin reductase, NADPH, and Emulgen 911. With cytochrome P-450b or P-450/P-420b preparations, a near quantitative conversion of degraded heme to bile pigments was observed. In the case of cytochrome P-450/P-420c approximately 70% of the degraded heme was accounted for as bilirubin but only cytochrome P-420c was appreciably degraded. The role of heme oxygenase in this reaction was supported by the following observations: (i) bilirubin formation was not observed when heme oxygenase was omitted from the assay system; (ii) the rate of degradation of the heme moiety was at least threefold greater with heme oxygenase and NADPH-cytochrome c (P-450) reductase than that observed with reductase alone; and (iii) the presence of Zn- or Sn-protoporphyrins (2 microM), known competitive inhibitors of heme oxygenase, resulted in 70-90% inhibition of bilirubin formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124760     DOI: 10.1016/0003-9861(88)90492-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.

Authors:  James R Reed; Warren J Huber; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2010-08-02       Impact factor: 3.922

2.  Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein.

Authors:  J F Ewing; M D Maines
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation.

Authors:  N Goda; K Suzuki; M Naito; S Takeoka; E Tsuchida; Y Ishimura; T Tamatani; M Suematsu
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Drug Metab Lett       Date:  2011-01

Review 5.  Carbon monoxide in lung cell physiology and disease.

Authors:  Stefan W Ryter; Kevin C Ma; Augustine M K Choi
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-08       Impact factor: 4.249

6.  Lead neurotoxicity: heme oxygenase and nitric oxide synthase activities in developing rat brain.

Authors:  Gottipolu R Reddy; Ambati Suresh; Karnam S Murthy; Chellu S Chetty
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

7.  Biliverdin targets enolase and eukaryotic initiation factor 2 (eIF2α) to reduce the growth of intraerythrocytic development of the malaria parasite Plasmodium falciparum.

Authors:  Eduardo Alves; Fernando V Maluf; Vânia B Bueno; Rafael V C Guido; Glaucius Oliva; Maneesh Singh; Pedro Scarpelli; Fahyme Costa; Robson Sartorello; Luiz H Catalani; Declan Brady; Rita Tewari; Celia R S Garcia
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

Review 8.  Carbon monoxide: present and future indications for a medical gas.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

Review 9.  Pharmacological Targeting of Heme Oxygenase-1 in Osteoarthritis.

Authors:  Yohei Sanada; Sho Joseph Ozaki Tan; Nobuo Adachi; Shigeru Miyaki
Journal:  Antioxidants (Basel)       Date:  2021-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.